Long-Term Outcomes and Responses to Retreatment in Patients With Melanoma Treated With PD-1 Blockade

PURPOSE: To analyze long-term outcomes after treatment discontinuation of anti–programmed death-1 (anti–PD-1) therapy in a cohort of patients with melanoma with the longest follow-up yet available to our knowledge, including a majority of patients treated outside of a clinical trial. We also assesse...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Oncol
Autors principals: Betof Warner, Allison, Palmer, Jessica S., Shoushtari, Alexander N., Goldman, Debra A., Panageas, Katherine S., Hayes, Sara A., Bajwa, Raazi, Momtaz, Parisa, Callahan, Margaret K., Wolchok, Jedd D., Postow, Michael A., Chapman, Paul B.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Clinical Oncology 2020
Matèries:
Rapid Communications
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7238490/
https://ncbi.nlm.nih.gov/pubmed/32053428
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.19.01464
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars